About iFast Diagnostics
iFAST is addressing the Antimicrobial Susceptibility Testing market, reducing the spread of antimicrobial resistance.
Sectors & Market Categories
Company Details
Corporate & Operational Profile
Primary Industry
Biotech & Healthcare
Funding Stage
Seed
Global Headquarters
Northampton, United Kingdom
Tracked Since
Oct 2, 2026
Web & Domain Identity
Official Website
ifastdiagnostics.com
Domain Registered Date
Apr 1, 2022
Social & Network Presence
X / Twitter Profile
Not linked
LinkedIn Corporate
Not linked
Company Milestones & Timeline
- Capital Raise
Seed announced
startupintros.com
- Capital Raise
Raised $6,420,000 · Seed
startupintros.com
- Milestone
Website domain registered
ifastdiagnostics.com
Investors & Backers
Investor firms and individual backers were not publicly disclosed in available round filings for iFast Diagnostics.
Funding History
Seed
· May 27, 2026
Undisclosed startupintros.com
Seed
· Nov 5, 2024
$6,420,000 startupintros.com
Press Coverage & Sources
Recently Funded Biotech & Healthcare Startups
View allVitalls
vitalls.ai
Seed Abu Dhabi, United Arab Emirates · Oct 2026
Hexagon Bio
hexagonbio.com
Series-B+ Oct 2026
RefloDx
reflodx.com
Seed Kaysville, United States · Oct 2026
HeyVoli
heyvoli.com
Pre-Seed Bangalore, India · Oct 2026
CureBay
curebay.com
Series-B+ Bhubaneshwar, India · Oct 2026
4Tissue
4tissue.com
Series-A Ghent, Belgium · Oct 2026